{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:09:20Z","timestamp":1789463360247,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-66961-9","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T07:43:55Z","timestamp":1786866235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Specific targeting of cancer cell mitochondria with a malaria drug improves pancreatic cancer outcome"],"prefix":"10.1038","volume":"16","author":[{"given":"Yan","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius F.","family":"Calsavara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Pandol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2549-8242","authenticated-orcid":false,"given":"Mouad","family":"Edderkaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,16]]},"reference":[{"issue":"1","key":"66961_CR1","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72 (1), 7\u201333 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"66961_CR2","doi-asserted-by":"crossref","unstructured":"Chapa-Gonz\u00e1lez, C., L\u00f3pez, K., Lomel\u00ed, K. M., Roacho-P\u00e9rez, J. A. & Stevens, J. C. A review on the efficacy and safety of nab-paclitaxel with gemcitabine in combination with other therapeutic agents as new treatment strategies in pancreatic cancer. Life (Basel) ;12, 3 (2022).","DOI":"10.3390\/life12030327"},{"issue":"11","key":"66961_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11864-021-00895-4","volume":"22","author":"TJ Ettrich","year":"2021","unstructured":"Ettrich, T. J. & Seufferlein, T. Systemic therapy for metastatic pancreatic cancer. Curr. Treat. Options Oncol. 22 (11), 106 (2021).","journal-title":"Curr. Treat. Options Oncol."},{"issue":"29","key":"66961_CR4","doi-asserted-by":"publisher","first-page":"21197","DOI":"10.1074\/jbc.M113.484576","volume":"288","author":"S Arora","year":"2013","unstructured":"Arora, S. et al. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor kappaB- and hypoxia-inducible factor 1alpha-mediated up-regulation of CXCR4. J. Biol. Chem. 288 (29), 21197\u201321207 (2013).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"66961_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.21037\/jgo.2017.02.02","volume":"8","author":"T Muranaka","year":"2017","unstructured":"Muranaka, T. et al. Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer. J. Gastrointest. Oncol. 8 (3), 566\u2013571 (2017).","journal-title":"J. Gastrointest. Oncol."},{"issue":"13","key":"66961_CR6","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.32033","volume":"125","author":"S Mrdenovic","year":"2019","unstructured":"Mrdenovic, S. et al. Targeting Burkitt lymphoma with a tumor cell-specific heptamethine carbocyanine-cisplatin conjugate. Cancer 125 (13), 2222\u20132232 (2019).","journal-title":"Cancer"},{"issue":"28","key":"66961_CR7","doi-asserted-by":"publisher","first-page":"8175","DOI":"10.1016\/j.biomaterials.2014.05.073","volume":"35","author":"JB Wu","year":"2014","unstructured":"Wu, J. B. et al. Near-infrared fluorescence imaging of cancer mediated by tumor hypoxia and HIF1alpha\/OATPs signaling axis. Biomaterials 35 (28), 8175\u20138185 (2014).","journal-title":"Biomaterials"},{"issue":"20","key":"66961_CR8","doi-asserted-by":"publisher","first-page":"10114","DOI":"10.18632\/oncotarget.2464","volume":"5","author":"C Shi","year":"2014","unstructured":"Shi, C. et al. Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1alpha\/OATPs signaling axis. Oncotarget 5 (20), 10114\u201310126 (2014).","journal-title":"Oncotarget"},{"issue":"2","key":"66961_CR9","doi-asserted-by":"publisher","first-page":"e88967","DOI":"10.1371\/journal.pone.0088967","volume":"9","author":"C Shao","year":"2014","unstructured":"Shao, C. et al. Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer. PLoS One. 9 (2), e88967 (2014).","journal-title":"PLoS One"},{"issue":"2","key":"66961_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.juro.2012.09.056","volume":"189","author":"X Yang","year":"2013","unstructured":"Yang, X. et al. Optical imaging of kidney cancer with novel near infrared heptamethine carbocyanine fluorescent dyes. J. Urol. 189 (2), 702\u2013710 (2013).","journal-title":"J. Urol."},{"issue":"10","key":"66961_CR11","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1158\/1078-0432.CCR-10-0059","volume":"16","author":"X Yang","year":"2010","unstructured":"Yang, X. et al. Near IR heptamethine cyanine dye-mediated cancer imaging. Clin. Cancer Res. 16 (10), 2833\u20132844 (2010).","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"66961_CR12","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1517\/13543784.9.8.1815","volume":"9","author":"RN Price","year":"2000","unstructured":"Price, R. N. Artemisinin drugs: novel antimalarial agents. Expert Opin. Investig. Drugs. 9 (8), 1815\u20131827 (2000).","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"9","key":"66961_CR13","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1128\/AAC.01585-07","volume":"52","author":"J Nagelschmitz","year":"2008","unstructured":"Nagelschmitz, J. et al. First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone. Antimicrob. Agents Chemother. 52 (9), 3085\u20133091 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"66961_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.etap.2017.12.004","volume":"57","author":"X Li","year":"2018","unstructured":"Li, X. et al. The selectivity of artemisinin-based drugs on human lung normal and cancer cells. Environ. Toxicol. Pharmacol. 57, 86\u201394 (2018).","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"5","key":"66961_CR15","doi-asserted-by":"publisher","first-page":"e37222","DOI":"10.1371\/journal.pone.0037222","volume":"7","author":"R Kong","year":"2012","unstructured":"Kong, R. et al. Dihydroartemisinin enhances Apo2L\/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5. PLoS One. 7 (5), e37222 (2012).","journal-title":"PLoS One"},{"issue":"11","key":"66961_CR16","first-page":"e3628","volume":"10","author":"Y Waseem","year":"2018","unstructured":"Waseem, Y., Hasan, C. A. & Ahmed, F. Artemisinin: a promising adjunct for cancer therapy. Cureus 10 (11), e3628 (2018).","journal-title":"Cureus"},{"issue":"3","key":"66961_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00280-017-3251-7","volume":"79","author":"A Bhaw-Luximon","year":"2017","unstructured":"Bhaw-Luximon, A. & Jhurry, D. Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives. Cancer Chemother. Pharmacol. 79 (3), 451\u2013466 (2017).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"66961_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3109\/1061186X.2015.1016437","volume":"23","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Enhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles. J. Drug Target. 23 (6), 552\u2013567 (2015).","journal-title":"J. Drug Target."},{"issue":"17","key":"66961_CR19","first-page":"3582","volume":"43","author":"YF Wei","year":"2018","unstructured":"Wei, Y. F. et al. [Design, synthesis and antiproliferative activity in cancer cells of novel dihydropyrazolyl and pyrazolyl artemisinin-phenyl ethers]. Zhongguo Zhong Yao Za Zhi. 43 (17), 3582\u20133588 (2018).","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"Pt B","key":"66961_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.biochi.2014.10.001","volume":"107","author":"A Ganguli","year":"2014","unstructured":"Ganguli, A., Choudhury, D., Datta, S., Bhattacharya, S. & Chakrabarti, G. Inhibition of autophagy by chloroquine potentiates synergistically anti-cancer property of artemisinin by promoting ROS dependent apoptosis. Biochimie 107 (Pt B), 338\u2013349 (2014).","journal-title":"Biochimie"},{"issue":"12","key":"66961_CR21","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s00432-014-1771-7","volume":"140","author":"P Li","year":"2014","unstructured":"Li, P. et al. Synergic effects of artemisinin and resveratrol in cancer cells. J. Cancer Res. Clin. Oncol. 140 (12), 2065\u20132075 (2014).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"66961_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fcimb.2018.00256","volume":"8","author":"S Gunjan","year":"2018","unstructured":"Gunjan, S. et al. Artemisinin derivatives and synthetic trioxane trigger apoptotic cell death in asexual stages of plasmodium. Front. Cell. Infect. Microbiol. 8, 256 (2018).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"66961_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acs.molpharmaceut.5b00906","volume":"14","author":"Y Guan","year":"2017","unstructured":"Guan, Y. et al. Improving therapeutic potential of farnesylthiosalicylic acid: tumor specific delivery via conjugation with heptamethine cyanine dye. Mol. Pharm. 14 (1), 1\u201313 (2017).","journal-title":"Mol. Pharm."},{"key":"66961_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.07.028","volume":"67","author":"JB Wu","year":"2015","unstructured":"Wu, J. B. et al. Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor. Biomaterials 67, 1\u201310 (2015).","journal-title":"Biomaterials"},{"issue":"5","key":"66961_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","volume":"7","author":"SR Hingorani","year":"2005","unstructured":"Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 7 (5), 469\u2013483 (2005).","journal-title":"Cancer Cell."},{"issue":"3","key":"66961_CR26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/jcmm.17147","volume":"26","author":"N Wang","year":"2022","unstructured":"Wang, N. et al. Interfering with mitochondrial dynamics sensitizes glioblastoma multiforme to temozolomide chemotherapy. J. Cell. Mol. Med. 26 (3), 893\u2013912 (2022).","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"66961_CR27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1113\/JP271301","volume":"594","author":"C Vasquez-Trincado","year":"2016","unstructured":"Vasquez-Trincado, C. et al. Mitochondrial dynamics, mitophagy and cardiovascular disease. J. Physiol. 594 (3), 509\u2013525 (2016).","journal-title":"J. Physiol."},{"issue":"3","key":"66961_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward, P. S. & Thompson, C. B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer cell. 21 (3), 297\u2013308 (2012).","journal-title":"Cancer cell."},{"key":"66961_CR29","doi-asserted-by":"crossref","unstructured":"Weinberg, F. et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. eLife 107 (19), 8788\u20138793 (2010).","DOI":"10.1073\/pnas.1003428107"},{"key":"66961_CR30","doi-asserted-by":"publisher","first-page":"e02242","DOI":"10.7554\/eLife.02242","volume":"3","author":"WW Wheaton","year":"2014","unstructured":"Wheaton, W. W. et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. eLife 3, e02242 (2014).","journal-title":"eLife"},{"issue":"11","key":"66961_CR31","doi-asserted-by":"publisher","first-page":"e80580","DOI":"10.1371\/journal.pone.0080580","volume":"8","author":"MP Torres","year":"2013","unstructured":"Torres, M. P. et al. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy. PLoS One. 8 (11), e80580 (2013).","journal-title":"PLoS One"},{"issue":"6","key":"66961_CR32","doi-asserted-by":"publisher","first-page":"G1137","DOI":"10.1152\/ajpgi.00197.2005","volume":"289","author":"M Edderkaoui","year":"2005","unstructured":"Edderkaoui, M. et al. Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase. Am. J. Physiol. Gastrointest. liver Physiol. 289 (6), G1137\u2013G1147 (2005).","journal-title":"Am. J. Physiol. Gastrointest. liver Physiol."},{"issue":"37","key":"66961_CR33","doi-asserted-by":"publisher","first-page":"26646","DOI":"10.1074\/jbc.M702836200","volume":"282","author":"M Edderkaoui","year":"2007","unstructured":"Edderkaoui, M., Hong, P., Lee, J. K., Pandol, S. J. & Gukovskaya, A. S. Insulin-like growth factor-I receptor mediates the prosurvival effect of fibronectin. J. Biol. Chem. 282 (37), 26646\u201326655 (2007).","journal-title":"J. Biol. Chem."},{"issue":"5","key":"66961_CR34","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1053\/j.gastro.2007.08.022","volume":"133","author":"JK Lee","year":"2007","unstructured":"Lee, J. K. et al. NADPH oxidase promotes pancreatic cancer cell survival via inhibiting JAK2 dephosphorylation by tyrosine phosphatases. Gastroenterology 133 (5), 1637\u20131648 (2007).","journal-title":"Gastroenterology"},{"issue":"6","key":"66961_CR35","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1053\/j.gastro.2018.08.028","volume":"155","author":"M Edderkaoui","year":"2018","unstructured":"Edderkaoui, M. et al. An Inhibitor of GSK3B and HDACs kills pancreatic cancer cells and slows pancreatic tumor growth and metastasis in mice. Gastroenterology 155 (6), 1985\u201398e5 (2018).","journal-title":"Gastroenterology"},{"issue":"7","key":"66961_CR36","doi-asserted-by":"publisher","first-page":"7747","DOI":"10.18632\/oncotarget.6820","volume":"7","author":"M Edderkaoui","year":"2016","unstructured":"Edderkaoui, M. et al. HDAC3 mediates smoking-induced pancreatic cancer. Oncotarget 7 (7), 7747\u20137760 (2016).","journal-title":"Oncotarget"},{"issue":"D1","key":"66961_CR37","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013d7 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"66961_CR38","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"66961_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"66961_CR40","doi-asserted-by":"publisher","first-page":"50901","DOI":"10.1117\/1.JBO.21.5.050901","volume":"21","author":"C Shi","year":"2016","unstructured":"Shi, C., Wu, J. B. & Pan, D. Review on near-infrared heptamethine cyanine dyes as theranostic agents for tumor imaging, targeting, and photodynamic therapy. J. Biomed. Opt. 21 (5), 50901 (2016).","journal-title":"J. Biomed. Opt."},{"key":"66961_CR41","doi-asserted-by":"crossref","unstructured":"Ou, Y. et al. Novel DZ-SIM Conjugate targets cancer mitochondria and prolongs survival in pancreatic ductal adenocarcinoma. Adv. Ther. (Weinh) 5, 10 (2022).","DOI":"10.1002\/adtp.202200021"},{"issue":"12","key":"66961_CR42","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1158\/1535-7163.MCT-20-1095","volume":"20","author":"L Yin","year":"2021","unstructured":"Yin, L. et al. Novel mitochondria-based targeting restores responsiveness in therapeutically resistant human lung cancer cells. Mol. Cancer Ther. 20 (12), 2527\u20132538 (2021).","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"66961_CR43","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1021\/acs.molpharmaceut.3c00993","volume":"21","author":"Y Ou","year":"2024","unstructured":"Ou, Y. et al. Overcoming resistance in prostate cancer therapy using a DZ-simvastatin conjugate. Mol. Pharm. 21 (2), 873\u2013882 (2024).","journal-title":"Mol. Pharm."},{"issue":"1","key":"66961_CR44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s12885-023-10878-3","volume":"23","author":"S Mrdenovic","year":"2023","unstructured":"Mrdenovic, S. et al. A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models. BMC Cancer. 23 (1), 499 (2023).","journal-title":"BMC Cancer"},{"key":"66961_CR45","doi-asserted-by":"publisher","first-page":"1412767","DOI":"10.3389\/fgene.2024.1412767","volume":"15","author":"G Pollin","year":"2024","unstructured":"Pollin, G. et al. Ehmt2 inactivation in pancreatic epithelial cells shapes the transcriptional landscape and inflammation response of the whole pancreas. Front. Genet. 15, 1412767 (2024).","journal-title":"Front. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66961-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66961-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66961-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:09:58Z","timestamp":1789459798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66961-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,16]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66961"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-66961-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,16]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A joint DZ-ART patent was filed by Ruoxiang Wang and Yi Zhang.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors grant permission to the journal to publish the manuscript once accepted for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal studies were performed according to the guidance of IACUC and after the approval of IACUC Protocol # 10063, Cedars-Sinai Medical Center.","order":3,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"28708"}}